Description: The article summarizes results of a Milliman survey per the title. These products comprise about 40% of the total individual life market, and the survey covers a range of topics on these plans, which should be of interest to a large portion of the life industry.

Description: Full version of Product Matters! September 2006, Issue No. 66.

Description: Discussion of pricing and underwriting Long Term Care coverage that is combined with annuities or life insurance.

Description: This article summarizes key findings from an SOA research report conducted by Milliman on a wide range of living benefit riders with medically related triggers on life and annuity products. The SOA report includes a survey of direct writers, and interviews with many reinsurers. The article focuses on chronic illness accelerated benefit riders, long term care accelerated benefit riders, and the more comprehensive long term care linked benefit products that can pay out benefits that may be much higher than the underlying base plan values. Information on regulations governing these plans, mechanics of the products, sales, and pricing structures is included The intent is to enable the reader to appreciate the issues and opportunities related to these new, innovative designs that help address a range of consumer needs..

Description: Discussion of combination long-term care insurance and annuity products.

Description: This article gives the highlights of the 88-page report including detailed assumptions for products including universal life with secondary guarantees (ULSG), cash accumulation universal life (CashAccum), current assumption universal life (CAUL), indexed universal life (IUL) and variable universal life (VUL). The 29 companies and 83 products represented in the report allow for an interesting perspective on premium persistency assumptions used in pricing, cash flow testing (CFT) and generally accepted accounting principles (GAAP)/international financial reporting standard (IFRS) functions. This article covers some general results and ULSG-specific results.